Mitapivat: Phase 3 trial shows efficacy against sickle cell disease

An international phase 3 clinical trial is evaluating the efficacy and safety of mitapivat in patients with sickle cell disease.

Published 3sem1 sourceNotableupdated 3sem
Lire en français
≈ 12s
Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Follow topic →
Auto-synthesis from 1 media source · identified on October 23, 2026
← Back to home
Discover

Read more

All sante →